AlphaMark Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $13K | Hold |
369
| – | – | 0.01% | 411 |
|
|
2024
Q3 | $15K | Sell |
369
-201
| -35% | -$8.17K | 0.01% | 466 |
|
|
2024
Q2 | $27K | Buy |
570
+170
| +43% | +$8.05K | 0.01% | 411 |
|
|
2024
Q1 | $17K | Sell |
400
-100
| -20% | -$4.25K | 0.01% | 462 |
|
|
2023
Q4 | $25K | Hold |
500
| – | – | 0.01% | 424 |
|
|
2023
Q3 | $23K | Hold |
500
| – | – | 0.01% | 414 |
|
|
2023
Q2 | $21K | Hold |
500
| – | – | 0.01% | 308 |
|
|
2023
Q1 | $18K | Sell |
500
-50
| -9% | -$1.8K | 0.01% | 332 |
|
|
2022
Q4 | $21K | Hold |
550
| – | – | 0.01% | 286 |
|
|
2022
Q3 | $24K | Sell |
550
-5
| -0.9% | -$218 | 0.01% | 291 |
|
|
2022
Q2 | $21K | Hold |
555
| – | – | 0.01% | 308 |
|
|
2022
Q1 | $21K | Buy |
555
+375
| +208% | +$14.2K | 0.01% | 323 |
|
|
2021
Q4 | $5K | Sell |
180
-15
| -8% | -$417 | ﹤0.01% | 451 |
|
|
2021
Q3 | $7K | Sell |
195
-5
| -3% | -$179 | ﹤0.01% | 436 |
|
|
2021
Q2 | $8K | Buy |
+200
| New | +$8K | ﹤0.01% | 424 |
|
|
2017
Q3 | – | Sell |
-165
| Closed | -$8K | – | 518 |
|
|
2017
Q2 | $8K | Hold |
165
| – | – | ﹤0.01% | 369 |
|
|
2017
Q1 | $7K | Hold |
165
| – | – | ﹤0.01% | 366 |
|
|
2016
Q4 | $8K | Buy |
+165
| New | +$8K | ﹤0.01% | 334 |
|